Vanda Pharmaceuticals (VNDA) Leases (2019 - 2025)
Historic Leases for Vanda Pharmaceuticals (VNDA) over the last 7 years, with Q4 2025 value amounting to $7.3 million.
- Vanda Pharmaceuticals' Leases rose 3107.82% to $7.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 million, marking a year-over-year increase of 3107.82%. This contributed to the annual value of $7.3 million for FY2025, which is 3107.82% up from last year.
- According to the latest figures from Q4 2025, Vanda Pharmaceuticals' Leases is $7.3 million, which was up 3107.82% from $5.1 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Leases registered a high of $10.2 million during Q1 2021, and its lowest value of $5.1 million during Q3 2025.
- Over the past 5 years, Vanda Pharmaceuticals' median Leases value was $7.6 million (recorded in 2023), while the average stood at $7.6 million.
- Data for Vanda Pharmaceuticals' Leases shows a peak YoY increase of 3107.82% (in 2025) and a maximum YoY decrease of 2275.29% (in 2025) over the last 5 years.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Leases stood at $9.3 million in 2021, then decreased by 9.4% to $8.4 million in 2022, then fell by 15.44% to $7.1 million in 2023, then fell by 21.13% to $5.6 million in 2024, then skyrocketed by 31.08% to $7.3 million in 2025.
- Its Leases was $7.3 million in Q4 2025, compared to $5.1 million in Q3 2025 and $5.2 million in Q2 2025.